While the terms can seem appealing, there are short-term and long-term downsides to tapping that nest egg. » Read More
By: Lorie Konish
Tools on the market may help you or your financial advisor sift through thousands of rules to understand when it’s best to claim Social Security based on your situation. » Read More
Tax-related scams peak during filing season but are a constant threat, cheating individuals and the government out of millions of dollars.
Wealth managers are telling clients to defer their income and maximize their deductions before the president-elect takes office.
Fund managers are betting on a post-election future where inflation takes root, the economy shows real growth, and cash is no longer king.
Bill Miller tells CNBC that embattled drugmaker Valeant Pharmaceuticals will clean up its act
Bill Miller tells CNBC that the surge in stocks in the wake of Trump's unexpected victory was not so surprising.
Exchange-traded funds may be 'cool' among young investors, but advisors warn that they should be vetted as thoroughly as any mutual fund.
Why do people take bad financial advice from their friends and family? Because hearsay is easier than reality, say financial advisors.
Retirees' search for safe income is leading to some new and risky products. Get ready to do your homework and ask questions.
Financial advisors warn that near-certain high medical costs should be a key line item in any investor's retirement plan.
Financial advisor Sophia Bera, founder of Gen Y Planning, discusses 3 key moves millennials can make to ensure a bright financial future.
Whatever the reasons, passive investments continue to gain momentum, while actively managed mutual funds watch money leave their coffers.
In a world of big box retail and e-commerce, successful business owners are taking new paths to Main Street success.
Covid-19 is expected to be with us for years even if the colossal investment in treatments and vaccines eventually manages to contain and control the global pandemic. The world will look dramatically different in its wake. As businesses begin the shift from crisis mode to planning for the lasting impact of Covid, CNBC’s journalists will hunt for cases of companies and industries taking a leading role in shaping Our New Future.
CNBC’s financial reporters weigh in on what every investor needs to know when it comes to companies' earnings reports.
Morgan Stanley looked at which stocks haven't priced in a successful Covid-19 vaccine that will benefit from the increase in economic activity.
Wall Street analysts told clients this week there's a host of inexpensive stocks to buy during the market downturn.
"I think value will outperform over the next year with the reopening of the economy and the search for yield," Wharton School professor Jeremy Siegel told CNBC.